The German drug discovery and development company, 4SC AG, has announced plans to raise €25 to €30 million in a rights issue to existing shareholders. The new shares are being offered at €3 per share, or at about the current market price. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
